111 Capital trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 46.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,114 shares of the healthcare conglomerate's stock after selling 2,720 shares during the quarter. 111 Capital's holdings in UnitedHealth Group were worth $1,294,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Norges Bank purchased a new position in UnitedHealth Group in the 4th quarter worth about $4,376,167,000. T. Rowe Price Investment Management Inc. raised its stake in UnitedHealth Group by 141.9% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate's stock valued at $1,356,432,000 after purchasing an additional 2,410,128 shares during the period. Cardano Risk Management B.V. boosted its position in shares of UnitedHealth Group by 864.4% in the fourth quarter. Cardano Risk Management B.V. now owns 2,523,700 shares of the healthcare conglomerate's stock worth $833,099,000 after buying an additional 2,262,006 shares during the period. Bank of America Corp DE increased its holdings in shares of UnitedHealth Group by 21.8% in the 1st quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate's stock valued at $3,169,606,000 after purchasing an additional 2,097,859 shares during the period. Finally, Hsbc Holdings PLC grew its position in UnitedHealth Group by 87.5% during the fourth quarter. Hsbc Holdings PLC now owns 3,916,041 shares of the healthcare conglomerate's stock valued at $1,294,367,000 after purchasing an additional 1,826,948 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of research analysts have commented on UNH shares. KeyCorp boosted their target price on UnitedHealth Group from $400.00 to $475.00 and gave the company an "overweight" rating in a research note on Tuesday, July 14th. Royal Bank Of Canada raised their price target on shares of UnitedHealth Group from $463.00 to $478.00 and gave the company an "outperform" rating in a report on Friday, July 17th. Truist Financial increased their price objective on UnitedHealth Group from $440.00 to $480.00 and gave the company a "buy" rating in a report on Tuesday, July 14th. UBS Group upped their target price on UnitedHealth Group from $460.00 to $490.00 and gave the stock a "buy" rating in a research report on Friday, July 17th. Finally, Zacks Research raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Monday, July 13th. Two research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $455.92.
Check Out Our Latest Report on UnitedHealth Group
UnitedHealth Group Price Performance
NYSE:UNH opened at $401.52 on Monday. The firm has a market cap of $360.40 billion, a PE ratio of 25.84, a price-to-earnings-growth ratio of 1.40 and a beta of 0.62. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The company's 50-day moving average price is $415.74 and its two-hundred day moving average price is $352.85. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same quarter in the prior year, the company earned $4.08 EPS. The firm's quarterly revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 19.69 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group's payout ratio is 59.72%.
Insider Activity at UnitedHealth Group
In related news, CEO Patrick Hugh Conway sold 500 shares of UnitedHealth Group stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $410.00, for a total transaction of $205,000.00. Following the completion of the sale, the chief executive officer directly owned 16,497 shares of the company's stock, valued at $6,763,770. The trade was a 2.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.19% of the stock is currently owned by company insiders.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
